World
AI rollout rattles Teleperformance, but some say the stock could double
When CEO Daniel Julien took the stage in New York for a pivotal investors’ relations day in June, he knew the stakes were high. Julien’s company, the French outsourcing giant Teleperformance , had lost more than 75% of its value from its 2022 high. He was tasked with convincing his audience — investors and Wall […]
Read More
Stock futures are little changed after S&P 500 posts first winning session in three: Live updates
Traders work on the floor of the New York Stock Exchange on July 08, 2025 in New York City. Michael M. Santiago | Getty Images Stock futures were relatively unchanged on Wednesday evening after the S&P 500 recouped some of its losses from this week’s tariff-fueled slide. S&P 500 futures traded just above the flatline, […]
Read More
Trump announces 50% tariff on Brazil in retaliation for Bolsonaro trial, trade deficit
U.S. President Donald Trump answers questions during a multilateral lunch with African leaders in the State Dining Room of the White House July 9, 2025 in Washington, DC. Win McNamee | Getty Images President Donald Trump said Wednesday the U.S. will slap a 50% tariff on Brazil’s imports, partly in retaliation for the ongoing prosecution […]
Read More
OpenAI to release web browser in challenge to Google Chrome
Sam Altman, CEO of OpenAI, at the Hope Global Forums annual meeting in Atlanta on Dec. 11, 2023. Dustin Chambers | Bloomberg | Getty Images OpenAI is close to releasing an AI-powered web browser that will challenge Alphabet’s market-dominating Google Chrome, three people familiar with the matter told Reuters. The browser is slated to launch […]
Read More
Nvidia’s latest milestone shows this is still the AI bull market
Nvidia has shaken off concerns about tariffs and competition to hit a new Wall Street milestone, reinforcing that the artificial intelligence boom is still at the heart of this stock market rally. The chip giant briefly passed $4 trillion in market value on Wednesday, the first company ever to do so, and its shares are […]
Read More
Most Fed officials see rate cuts coming, but opinions vary widely on how many, minutes show
Federal Reserve officials diverged at their June meeting about how aggressively they would be willing to cut interest rates, split between concerns over tariff-fueled inflation and signs of labor market weakness and economic strength. Minutes from the June 17-18 meeting released Wednesday showed that policymakers largely held to a wait-and-see position on future rate moves. […]
Read More
Nvidia hits $4 trillion market cap, first company to do so
Nvidia CEO Jensen Huang attends a roundtable discussion at the Viva Technology conference dedicated to innovation and startups at Porte de Versailles exhibition center in Paris on June 11, 2025. Sarah Meyssonnier | Reuters Nvidia stock jumped more than 2% on Wednesday, topping a $4 trillion market cap for the first time as investors scooped […]
Read More
Samsung launches three new foldable smartphones as it fends off Chinese rivals
The Galaxy Z Fold 7 is super thin, measuring just 8.9 millimeters when closed and 4.2 millimeters when unfolded. Ryan Browne | CNBC Samsung on Wednesday launched three new folding smartphones — including thinner top-end devices and a cheaper version of its flip phone — as the tech giant looks to entice buyers to make the […]
Read More
Copper now costs way more in the U.S. than elsewhere. This could hit its economy hard
Close up of electrical engineer inspecting copper windings in an electrical engineering factory. Monty Rakusen | Digitalvision | Getty Images The cost of copper for U.S. buyers has rocketed after President Donald Trump said he would impose a 50% tariff on imports of the metal. It means that already elevated prices are now even higher […]
Read More
Merck shells out $10 billion for London-based lung therapy firm Verona
Bloomberg | Bloomberg | Getty Images Merck will buy UK-based Verona Pharma for about $10 billion, the companies said on Wednesday, strengthening the U.S. firm’s respiratory treatment portfolio in a bid to diversify its revenue source beyond blockbuster cancer drug. Merck has been leaning on its aging cancer immunotherapy Keytruda, the world’s top-selling prescription medicine, […]
Read More